The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH03-03-0170
Issue:2003: 90/5 (Nov) pp. 774-966
Pages:829-834

The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism

Philip S.Wells (1, 2, 5), Marc A. Rodger (1, 2, 5), Melissa A. Forgie (1, 2, 5), Nicole J. Langlois (5) , Linlea Armstrong (6), Nancy L. Carson (3, 4, 6), James Jaffey (5)
Departments of (1) Medicine, (2) Epidemiology and Community Medicine, (3) Pediatrics and (4) Biochemistry, Microbiology and Immunology, University of Ottawa, Canada (5) Ottawa Health Research Institute, Canada (6) Children’s Hospital of Eastern Ontario,

Summary

The deletion/deletion (D/D) genotype of the angiotensin convertingenzyme (ACE) has been purported to be a risk for postoperativethrombosis.This D/D genotype has not been evaluatedas a risk factor for idiopathic venous thromboembolism(VTE).The primary objective of the present study was to determinewhether the D/D genotype of ACE is independently associatedwith the occurrence of idiopathic venous thromboembolic disease.We prospectively enrolled consecutive patients with at leastone objectively confirmed idiopathic VTE. Friends of cases wererecruited as controls and matched to cases by sex, ethnicity,and age. Patients were tested for the ACE I/D polymorphismin addition to factor V Leiden, prothrombin G20210A, and factorVIII levels.Three hundred cases and 300 controls were enrolled; 97% wereCaucasian. There were 148 females and 152 males in each groupwith a mean age of 56.21 years (SD=15.33). The ACE D/Dgenotype was present in 25.3% of cases and 32.4% of controlsfor an adjusted odds ratio of 0.66 (95% CI = 0.433 to 0.997).We can conclude that the ACE D/D genotype is protectiveagainst idiopathic venous thromboembolism.

DOI

http://dx.doi.org/10.1160/TH03-03-0170

Articles

You've 655 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...